1. Avedisova, A.S; Akhapkin, R.V. Problems of clinical assessment of the tolerability of therapy with psychotropic drugs. Psychiatry and Psychopharmacotherapy. P.B. Gannushkin Journal. 2005, 1(7): 17-20 (In Russ.).
2. Gorobets, L.N. Endocrinological aspects of the problem of tolerability of neuroleptic therapy in patients with schizophrenia (age and gender characteristics). Psychiatry and Psychopharmacotherapy. P.B. Gannushkin Journal. 2012, 14 (1): 1-47 (In Russ.).
3. Krasnov, V.N.; Gurovicha, I.Ia. Clinical guidelines: models for the diagnosis and treatment of mental and behavioral disorders. Social and Clinical Psychiatry. 1999 (In Russ.).
4. Cadenhead, K.S. Startle reactivity and prepulse inhibition in prodromal and early psychosis: effects of age, antipsychotics, tobacco and cannabis in a vulnerable population. Psychiatry Res. 2011. 188(2): 208-216.
5. Moriarty, P.J.; Lieber, D.; Bennett, A. et al. Gender differences in poor outcome patients with lifelong schizophrenia. Schizophr. Bull. 2001, 27(1): 103-113.